PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 11 filers reported holding PHOENIX BIOTECH ACQUISITION in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $264,264 | – | 52,252 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 542,376 | $5,570,364 | 2.24% |
| DIFESA CAPITAL MANAGEMENT, LP | 125,000 | $1,287,500 | 1.00% |
| Lynwood Capital Management Inc. | 59,615 | $613 | 0.74% |
| Sage Rock Capital Management LP | 183,998 | $1,889,715 | 0.59% |
| HGC Investment Management Inc. | 1,000,000 | $10,180 | 0.44% |
| GRITSTONE ASSET MANAGEMENT LLC | 34,026 | $349,457 | 0.44% |
| MMCAP International Inc. SPC | 370,000 | $3,796,200 | 0.38% |
| METEORA CAPITAL, LLC | 168,532 | $1,730,874 | 0.37% |
| Exos TFP Holdings LLC | 125,771 | $1,290,410 | 0.36% |
| Bulldog Investors, LLP | 90,650 | $931,429 | 0.28% |